ImmunoPrecise M&A Summary
ImmunoPrecise has acquired 3 companies, including 2 in the last 5 years. It has also divested 1 asset.
ImmunoPrecise’s largest acquisition to date was in 2022, when it acquired BioStrand BV for $23M. It’s largest disclosed sale occurred in 2025, when it sold ImmunoPrecise Antibodies B.V. to Avian Vaccine Services for $12M. ImmunoPrecise has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include technology hardware (34%) and internet software and services (34%).
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 3
- M&A Buy/Sell Connections 2
Unlimited Searches
